B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Clonixin

43 PubMed studies analyzed · 3 RCTs · Evidence Score: 41.7

Research Domains

Clonixin has been studied across 17 research domains including 🔬 Inflammation, 💊 Pain, 🦴 Bone & Joint, ❤️ Cardiovascular, 😴 Sleep. The primary research focus is 🔬 Inflammation with 49% of studies addressing this area.

Loading evidence profile...

This evidence profile for Clonixin is generated deterministically from 43 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.